Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2019 | Prostate Cancer: radiation with or without androgen-deprivation

Nicolas Magne • 2 Jun 2019
ASCO 2019
Prostate Cancer Goserelin
GETUG-AFU

Nicolas Magne, MD, PhD, of the Lucien Neuwirth Oncology Institute, St-Priest-en-Jarez, France, tells us about the GETUG-AFU trial (NCT00423475), which investigated radiation therapy with or without goserelin in treating patients who have undergone surgery for recurrent or refractory prostate cancer. This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

More from Nicolas Magne

1:07
Changing US prostate cancer practices
Nicolas Magne • 2 Jun 2019
1:55
Radiotherapy: the need for further research
Nicolas Magne • 2 Jun 2019

Related Videos

4:05
Evaluating triplet therapy in metastatic hormone sensitive prostate cancer
Nick James • 24 Apr 2024
10:42
Management of prostate cancer from the patient perspective
David Matheson • 11 Apr 2024
2:44
The effect of hypoxia on lipid metabolism and prostate cancer tumor growth
Teemu Murtola • 9 Apr 2024
3:07
Serum thymidine kinase 1 as a predicative biomarker in prostate cancer
Teemu Murtola • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals